Aquestive Therapeutics, Inc. (AQST) Capital expenditures 2017–2025
Aquestive Therapeutics, Inc. (AQST) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$562,000FY2025 · since FY2017: $2.1M → $562,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $562,000 | +253.5% |
| FY2024 | $159,000 | -84.0% |
| FY2023 | $995,000 | -2.8% |
| FY2022 | $1.0M | +12.2% |
| FY2021 | $913,000 | +76.6% |
| FY2020 | $517,000 | -22.0% |
| FY2019 | $663,000 | -63.7% |
| FY2018 | $1.8M | -11.8% |
| FY2017 | $2.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice